4. Scottish ophthalmologist Coats
Massive sub
retinal Exudation
No significant
vascular
abnormalities
Massive sub retinal
Exudation
No significant
vascular abnormalities
Internal
Hemorrhage
Massive sub retinal
Exudation
No significant
vascular abnormalities
Internal
Hemorrhage
Massive sub
retinal Exudation
Frank retinal
arterioles and venous
malformation
Massive sub
retinal Exudation
Frank retinal
arterioles and venous
malformation
Group I Group II Group III
5. • Leber’s multiple miliary aneurysms—
only aneurysmal dilatations.(early form of
coats)
• Coats disease—multiple aneurysmal
dilatations, sub retinal exudation & intra
retinal haemorrahage.
• Von hipple’s disease -- Massive sub retinal
Exudation, Frank retinal arterioles and venous
malformation.
19. Ocular conditions that can
simulate
Juvenile Coats disease
Retinoblastoma
Retinal detachment
Congenital cataract
Norrie disease
Persistent hyperplastic
primary vitreous
Ocular toxocariasis
At any age
Vasculitis
Ocular toxoplasmosis
Type 1 idiopathic
juxtafoveolar telangiectasis
20. Retinoblastoma
• Dilated vessels are
continuous with the large
vascular trunks that extend
into the tumor.
• CT and USG --pick up
calcium deposits
• FFA differentiates both.
Coats disease
• the dilated vessels do not
extend into the subretinal
mass
21. • B SCAN- Exudative , with an absence of the
calcifications.(COATS)
• CT -- characterize intraocular morphology,
quantify subretinal densities, detect calcium,
and identify vascularity within the subretinal
space-(RB)
• Examination of subretinal fluid- cholesterol
crystals and pigment-laden macrophages in
the absence of tumor cells(COATS)
22. Leber miliary aneurysms
Presents usually in early adult life
Temporal fusiform and
saccular vascular
dilatation
Hard exudates may
threaten macula
Photocoagulation may be
beneficial
23. Idiopathic juxtafoveolar retinal telangiectasia
Group 1
• Unilateral, telangiectasia
temporal to fovea
• May benefit from
photocoagulation
• Bilateral, symmetrical perifoveal
telangiectasia
• Occasionally may benefit from
photocoagulation
Group 2
Presents in middle or old age
• Good prognosis • Guarded prognosis
• Bilateral, severe, perifovea
telangiectasia and capillar
occlusion
• Photocoagulation not
beneficial
Group 3
• Poor prognosis
24. Treatment
The goal of treatment mainly is to close
telangiectesia so that further leakage will not
occur
25. Treatment
Stage I
• Documentation (CFP and FFA)
• Follow up conservatively
• Intervention (if sub-retinal fluid and
exudation develop)
26. Treatment
Stage II to IV:
• Laser photocoagulation
• Cryotherapy
• Intra vitreal anti VEGF
• Surgical Intervention
27. Ablative therapies
Laser Photocoagulation
• Less severe cases of
exudation
• With or without RD
• Vascular leakage
• Non perfusion
• NVE
Laser Photocoagulation
• Less severe cases of
exudation
• With or without RD
• Vascular leakage
• Non perfusion
• NVE
Cryotherapy
• Laser is ineffective
• Extensive sub-retinal
exudation
• RD
• Drain sub retinal
exudation
30. • Coats disease is a serious eye disease
• Repeated treatment are needed to stabilize
the affected eyes
• Lifelong and serial monitoring required.
• Careful distinction of coats disease from
retinoblastoma is important